Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-10
2007-07-10
Solola, Taofiq (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S254030, C514S322000, C514S361000, C544S107000, C544S121000, C546S199000, C548S126000
Reexamination Certificate
active
10811292
ABSTRACT:
Certain amidophenyl-sulfanylamino-benzo[1,2,5]thiadiazole compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.
REFERENCES:
patent: 5534530 (1996-07-01), Frehel et al.
patent: 6239131 (2001-05-01), Shinozaki et al.
patent: 0 620 221 (1994-10-01), None
patent: WO/0078145 (2000-06-01), None
patent: WO 02/42248 (2002-05-01), None
patent: WO 02/90353 (2002-11-01), None
patent: WO 2004013087 (2004-02-01), None
Petrov et al., Meditsinskaya Parazitologiya I Parazitamye Bolexni, (1996) vol. 4, pp. 40-42.
Mikhailitsyn et al., Meditsinskaya Parazitologiya I Parazitarnye Bolexni, (1991) vol. 6, pp. 52-53.
Mikhailitsyn et al., Meditsinskaya Parazitologiya I Parazitarnye Bolexni, (1991) vol. 2, pp. 36-38.
International Search Report dated Mar. 15, 2005, for corresponding international application PCT/US2004/009589.
Black, J.W. and S.B. Kalindjian. Gastrin Agonists and Antagonists. Pharmacol. Toxicol (2002) 91:275-281.
de Tullio, P. et al. Therapeutic and Chemical Developments of Cholecystokinin Receptor Ligands. Exp. Opin. Invest. Drugs (2000) 9(1):129-146.
Herranz, R. Cholecystokinin Antagonists: Pharmacological and Therapeutic Potential. Med. Res. Rev. (2003) 23(5):559-605.
Revel, L. and F. Makovec. Update on Nonpeptide CCK-B Receptor Antagonists. Drugs Future. (1998) 23(7):751-766.
McDonald, I.M. CCK2 Receptor Antagonists. Exp. Opin. Ther. Patents. (2001) 11(3):445-462.
Morton, M.F. et al. Pharmacological Comparison of the Alternatively Spliced Short and Long CCK2 Receptors. Br. J. Pharmacol. (2003) 140(1):218-224.
Tracy, H.J. and R.A. Gregory. Physiological Properties of a Series of Peptides Structurally Related to Gastrin 1. Nature (London). (1964) 204:935-938.
Varnavas, A. et al. Anthranilic Acid Based CCK1 Antagonists: The 2 -Indole Moiety May Represent a “Needle” According to the Recent Homonymous Concept. Eur. J. Med. Chem. (2004) 39:85-97.
Varnavas, A. et al. Anthranilic Acid Derivatives: A New Class of Non-Peptide CCK1 Receptor Antagonists. Bioorg. Med. Chem. (2003) 11:741-751.
Varnavas, A. et al. Synthesis of N-Terminal Substituted Anthranilic Acid Dimer Derivatives for Evaluation on CCK Receptors. II Farmaco. (2001) 56:555-564.
Allison Brett
McAtee Laura C.
Phuong Victor K.
Rabinowitz Michael H.
Shankley Nigel P.
Harbour John
Janssen Pharmaceutica N.V.
Solola Taofiq
LandOfFree
Benzo[1,2,5]thiadiazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzo[1,2,5]thiadiazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzo[1,2,5]thiadiazole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3746588